GTBP GT Biopharma Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

View a ticker or compare two or three

Compare

Ad is loading...

A.I. Advisor

published Earnings

GTBP is expected to report earnings to rise 41.67% to -8 cents per share on March 27

GT Biopharma GTBP Stock Earnings Reports

Q4'23

Est.

$-0.09

Q3'23

Beat

by $0.03

Q2'23

Beat

by $0.05

Q1'23

Beat

by $0.16

Q4'22

Missed

by $0.01

The last earnings report on November 01 showed earnings per share of -5 cents, beating the estimate of -9 cents. With 806.00 shares outstanding, the current market capitalization sits at 5.95M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

8000 Marina Boulevard

Phone

+1 415 919-4040

Employees

Web

https://www.gtbiopharma.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
MRIN	2.47	0.08	+3.35%
Marin Software
EMN	97.14	0.76	+0.79%
Eastman Chemical Company
MCBS	30.71	0.22	+0.72%
MetroCity Bankshares
ICUI	124.47	-1.39	-1.10%
ICU Medical
UEIC	11.49	-0.21	-1.79%
Universal Electronics

GTBP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBP has been loosely correlated with NBY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GTBP jumps, then NBY could also see price increases.

Ticker / NAME	Correlation To GTBP	1D Price Change %
GTBP	100%	+0.55%
NBY - GTBP	38% Loosely correlated	-10.19%
AMRN - GTBP	33% Poorly correlated	+0.87%
MDGL - GTBP	32% Poorly correlated	+0.47%
VKTX - GTBP	31% Poorly correlated	+28.31%
BMEA - GTBP	29% Poorly correlated	+0.37%
More